DEM Bio
Novel Targets for Solid Tumors. First-in-Class Cancer Therapeutics.
Boston, United States · Founded 2022 · $70.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- dembiopharma.com
- Total Funding
- $70.0M
- Last Round
- $70.0M SeedJun 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.
About
DEM BioPharma is a clinical-stage biopharmaceutical company dedicated to discovering novel targets for solid tumors and developing innovative, first-in-class cancer therapeutics. The company's lead program, DEM301, is an antibody-drug conjugate (ADC) targeting a novel innate immune checkpoint pathway. DEM Bio's approach focuses on unleashing macrophages and immune phagocytes to eliminate tumors by targeting 'don't eat me' (DEM) signals — a distinct mechanism from conventional checkpoint inhibitors. Headquartered in Cambridge, Massachusetts, DEM Bio was founded in 2022 and is backed by a world-class scientific and operating team.
Summary
DEM Bio is a Life Sciences company based in Boston, United States, founded in 2022. It has raised $70.0M in total across 1 round, most recently a $70.0M Seed round in Jun 2022. Investors include Longwood Fund, Alta Partners and Insight Partners.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2022
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dem-bio"><img src="https://indexed.vc/api/badge/company/dem-bio" alt="DEM Bio on Indexed.vc" width="260" height="76" /></a>